Safety and Tolerability Study of the Helical Intravitreal Triamcinolone Implant in Diabetic Macular Edema
Status:
Completed
Trial end date:
2009-05-01
Target enrollment:
Participant gender:
Summary
This Phase 1 study will evaluate the safety, tolerability and duration of effect of a helical
intravitreal triamcinolone implant for the treatment of diabetic macular edema over a
three-year period.